Travere Therapeutics
Price & Volume
Stats
See moreOpen | $21.48 |
Previous Close | $23.58 |
Day Range | $21.01-$22.81 |
52W Range | $5.12-$25.29 |
Market Cap | $2B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $203.4M |
Revenue Growth (YoY) | 69.6% |
Gross Profit (12 Mos) | -$21.4M |
Diluted EPS | -$4.52 |
News
See moreYahoo Finance • 23 hours ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 8 days ago
Travere Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 9 days ago
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 10 days ago
Travere Therapeutics to Submit sNDA for FILSPARI® (sparsentan) in FSGS
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 380 |
